Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic Agents.
Pro-uPA-catalyzed plasminogen
antithrombotic agents
fibrinolytic activity
modification
pyran-isoindolone derivatives
Journal
Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729
Informations de publication
Date de publication:
15 Apr 2021
15 Apr 2021
Historique:
received:
15
03
2021
revised:
09
04
2021
accepted:
13
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
8
6
2021
Statut:
epublish
Résumé
2,5-Bis-[8-(4,8-dimethyl-nona-3,7-dienyl)-5,7-dihydroxy-8-methyl-3-keto-1,2,7,8-teraahydro-6
Identifiants
pubmed: 33921137
pii: md19040218
doi: 10.3390/md19040218
pmc: PMC8071544
pii:
doi:
Substances chimiques
Fibrinolytic Agents
0
Isoindol-1-one
0
Isoindoles
0
Pyrans
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NSFC-Liaoning Joint Fund
ID : No. 81502955
Organisme : the Doctoral Scientific Research Foundation of Shanghai Ocean University
ID : No. A2030214300077
Organisme : the Young Teachers Training Program of Shanghai
ID : No. A12056160002
Organisme : the Plan of Innovation Action in Shanghai
ID : No. 14431906000
Organisme : Ruilong Sheng
ID : M1420-01-0145-FEDER-000005-Centro de Química da Madeira-CQM+(Madeira 14-20)
Organisme : Ruilong Sheng
ID : ARDITI-2017-ISG-00
Organisme : Portuguese Government funds
ID : project PEst-OE/QUI/UI0674/2019, CQM
Références
Bioorg Med Chem. 2019 May 1;27(9):1903-1910
pubmed: 30926314
Neurosurgery. 2002 Nov;51(5):1319-27; discussion 1327-9
pubmed: 12383381
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Dec 30;942-943:77-82
pubmed: 24216275
PLoS One. 2012;7(4):e34344
pubmed: 22509290
Methods Mol Med. 2004;88:165-9
pubmed: 14634227
Drugs. 1989 Nov;38(5):801-21
pubmed: 2689138
J Vasc Interv Radiol. 1995 Nov-Dec;6(6 Pt 2 Suppl):62S-65S
pubmed: 8770844
Ann Intern Med. 2020 Sep 15;173(6):505-506
pubmed: 32926827
J Nat Prod. 1997 Jan;60(1):52-60
pubmed: 9014353
Circ Res. 2016 Apr 29;118(9):1409-24
pubmed: 27126650
Med Chem. 2020;16(1):39-51
pubmed: 31208311
Drugs. 2010 Nov 12;70(16):2153-70
pubmed: 20964458
Bioact Mater. 2021 Jan 22;6(8):2261-2280
pubmed: 33553814
Biomaterials. 2020 Nov;258:120297
pubmed: 32818824
Cancer Lett. 2010 Dec 1;298(1):88-98
pubmed: 20638780
Pediatr Investig. 2021 Mar 22;5(1):3-5
pubmed: 33778420
Expert Opin Investig Drugs. 2003 May;12(5):781-97
pubmed: 12720490
Cancer Chemother Pharmacol. 2017 Feb;79(2):389-397
pubmed: 28054203
Eur J Med Chem. 2018 Feb 25;146:299-317
pubmed: 29407959
J Immunol Methods. 1985 Nov 28;84(1-2):85-94
pubmed: 3934287
Mar Drugs. 2019 Nov 20;17(12):
pubmed: 31757085
Indian J Crit Care Med. 2010 Oct;14(4):188-95
pubmed: 21572750
J Nat Prod. 2007 Mar;70(3):461-77
pubmed: 17309302
Mol Cell Biol. 1995 Jun;15(6):3032-40
pubmed: 7539102
Med Chem. 2020;16(6):784-795
pubmed: 31309897
Lancet. 2008 Dec 6;372(9654):1988-96
pubmed: 18945485
Br Heart J. 1994 Sep;72(3):222-5
pubmed: 7946770
Tech Vasc Interv Radiol. 2001 Jun;4(2):92-8
pubmed: 11981794
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
Bioorg Chem. 2020 Nov;104:104342
pubmed: 33142412
Cancers (Basel). 2011 Mar 15;3(1):1351-71
pubmed: 24212665
Am J Cardiol. 1996 Jul 1;78(1):1-8
pubmed: 8712096
Cell. 1996 Jun 14;85(6):803-15
pubmed: 8681376
Int J Environ Res Public Health. 2020 Sep 14;17(18):
pubmed: 32937847
Am J Med. 2000 Jul;109(1):52-8
pubmed: 10936478
Arch Pharm Res. 2015 Aug;38(8):1530-40
pubmed: 25475097
J Nat Prod. 2003 Jul;66(7):1022-37
pubmed: 12880330